Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

Jianjian Jin, Marianna Sabatino, Robert Somerville, John R. Wilson, Mark E. Dudley, David F. Stroncek, Steven A. Rosenberg

Research output: Contribution to journalArticle

Abstract

Adoptive cell therapy of metastatic melanoma with autologous tumor infiltrating lymphocytes (TIL) is clinically effective, but TIL production can be challenging. Here we describe a simplified method for initial TIL culture and rapid expansion in gas-permeable flasks. TIL were initially cultured from tumor digests and fragments in 40 mL capacity flasks with a 10 cm gas-permeable silicone bottom, G-Rex10. A TIL rapid expansion protocol (REP) was developed using 500 mL capacity flasks with a 100 cm 2 gas-permeable silicone bottom, G-Rex100. TIL growth was successfully initiated in G-Rex10 flasks from tumor digests from 13 of 14 patients and from tumor fragments in all 11 tumor samples tested. TIL could then be expanded to 8-10× 10 cells in a 2-step REP that began by seeding 5× 10 TIL into a G-Rex100 flask, followed by expansion at day 7 into 3 G-Rex100 flasks. To obtain the 30-60× 10 cells used for patient treatment, we seeded 6 G-Rex100 flasks with 5× 10 cells and expanded into 18 G-Rex100 flasks. Large-scale TIL REP in gas-permeable flasks requires approximately 9-10 L of media, about 3-4 times less than other methods. In conclusion, TIL initiation and REP in gas-permeable G-Rex flasks require fewer total vessels, less media, less incubator space, and less labor than initiation and REP in 24-well plates, tissue culture flasks, and bags. TIL culture in G-Rex flasks will facilitate the production of TIL at the numbers required for patient treatment at most cell processing laboratories.

Original languageEnglish (US)
Pages (from-to)283-292
Number of pages10
JournalJournal of Immunotherapy
Volume35
Issue number3
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Tumor-Infiltrating Lymphocytes
Gases
Growth
Therapeutics
Silicones
Neoplasms
Incubators
Lymphocyte Count
Cell- and Tissue-Based Therapy
Melanoma

Keywords

  • adoptive cell therapy
  • cancer
  • G-Rex flasks
  • melanoma
  • tumor infiltrating lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Cancer Research
  • Pharmacology

Cite this

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. / Jin, Jianjian; Sabatino, Marianna; Somerville, Robert; Wilson, John R.; Dudley, Mark E.; Stroncek, David F.; Rosenberg, Steven A.

In: Journal of Immunotherapy, Vol. 35, No. 3, 04.2012, p. 283-292.

Research output: Contribution to journalArticle

Jin, Jianjian ; Sabatino, Marianna ; Somerville, Robert ; Wilson, John R. ; Dudley, Mark E. ; Stroncek, David F. ; Rosenberg, Steven A. / Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. In: Journal of Immunotherapy. 2012 ; Vol. 35, No. 3. pp. 283-292.
@article{3219d7339f3f45ffbe109771cbe06f8e,
title = "Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment",
abstract = "Adoptive cell therapy of metastatic melanoma with autologous tumor infiltrating lymphocytes (TIL) is clinically effective, but TIL production can be challenging. Here we describe a simplified method for initial TIL culture and rapid expansion in gas-permeable flasks. TIL were initially cultured from tumor digests and fragments in 40 mL capacity flasks with a 10 cm gas-permeable silicone bottom, G-Rex10. A TIL rapid expansion protocol (REP) was developed using 500 mL capacity flasks with a 100 cm 2 gas-permeable silicone bottom, G-Rex100. TIL growth was successfully initiated in G-Rex10 flasks from tumor digests from 13 of 14 patients and from tumor fragments in all 11 tumor samples tested. TIL could then be expanded to 8-10× 10 cells in a 2-step REP that began by seeding 5× 10 TIL into a G-Rex100 flask, followed by expansion at day 7 into 3 G-Rex100 flasks. To obtain the 30-60× 10 cells used for patient treatment, we seeded 6 G-Rex100 flasks with 5× 10 cells and expanded into 18 G-Rex100 flasks. Large-scale TIL REP in gas-permeable flasks requires approximately 9-10 L of media, about 3-4 times less than other methods. In conclusion, TIL initiation and REP in gas-permeable G-Rex flasks require fewer total vessels, less media, less incubator space, and less labor than initiation and REP in 24-well plates, tissue culture flasks, and bags. TIL culture in G-Rex flasks will facilitate the production of TIL at the numbers required for patient treatment at most cell processing laboratories.",
keywords = "adoptive cell therapy, cancer, G-Rex flasks, melanoma, tumor infiltrating lymphocytes",
author = "Jianjian Jin and Marianna Sabatino and Robert Somerville and Wilson, {John R.} and Dudley, {Mark E.} and Stroncek, {David F.} and Rosenberg, {Steven A.}",
year = "2012",
month = "4",
doi = "10.1097/CJI.0b013e31824e801f",
language = "English (US)",
volume = "35",
pages = "283--292",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

AU - Jin, Jianjian

AU - Sabatino, Marianna

AU - Somerville, Robert

AU - Wilson, John R.

AU - Dudley, Mark E.

AU - Stroncek, David F.

AU - Rosenberg, Steven A.

PY - 2012/4

Y1 - 2012/4

N2 - Adoptive cell therapy of metastatic melanoma with autologous tumor infiltrating lymphocytes (TIL) is clinically effective, but TIL production can be challenging. Here we describe a simplified method for initial TIL culture and rapid expansion in gas-permeable flasks. TIL were initially cultured from tumor digests and fragments in 40 mL capacity flasks with a 10 cm gas-permeable silicone bottom, G-Rex10. A TIL rapid expansion protocol (REP) was developed using 500 mL capacity flasks with a 100 cm 2 gas-permeable silicone bottom, G-Rex100. TIL growth was successfully initiated in G-Rex10 flasks from tumor digests from 13 of 14 patients and from tumor fragments in all 11 tumor samples tested. TIL could then be expanded to 8-10× 10 cells in a 2-step REP that began by seeding 5× 10 TIL into a G-Rex100 flask, followed by expansion at day 7 into 3 G-Rex100 flasks. To obtain the 30-60× 10 cells used for patient treatment, we seeded 6 G-Rex100 flasks with 5× 10 cells and expanded into 18 G-Rex100 flasks. Large-scale TIL REP in gas-permeable flasks requires approximately 9-10 L of media, about 3-4 times less than other methods. In conclusion, TIL initiation and REP in gas-permeable G-Rex flasks require fewer total vessels, less media, less incubator space, and less labor than initiation and REP in 24-well plates, tissue culture flasks, and bags. TIL culture in G-Rex flasks will facilitate the production of TIL at the numbers required for patient treatment at most cell processing laboratories.

AB - Adoptive cell therapy of metastatic melanoma with autologous tumor infiltrating lymphocytes (TIL) is clinically effective, but TIL production can be challenging. Here we describe a simplified method for initial TIL culture and rapid expansion in gas-permeable flasks. TIL were initially cultured from tumor digests and fragments in 40 mL capacity flasks with a 10 cm gas-permeable silicone bottom, G-Rex10. A TIL rapid expansion protocol (REP) was developed using 500 mL capacity flasks with a 100 cm 2 gas-permeable silicone bottom, G-Rex100. TIL growth was successfully initiated in G-Rex10 flasks from tumor digests from 13 of 14 patients and from tumor fragments in all 11 tumor samples tested. TIL could then be expanded to 8-10× 10 cells in a 2-step REP that began by seeding 5× 10 TIL into a G-Rex100 flask, followed by expansion at day 7 into 3 G-Rex100 flasks. To obtain the 30-60× 10 cells used for patient treatment, we seeded 6 G-Rex100 flasks with 5× 10 cells and expanded into 18 G-Rex100 flasks. Large-scale TIL REP in gas-permeable flasks requires approximately 9-10 L of media, about 3-4 times less than other methods. In conclusion, TIL initiation and REP in gas-permeable G-Rex flasks require fewer total vessels, less media, less incubator space, and less labor than initiation and REP in 24-well plates, tissue culture flasks, and bags. TIL culture in G-Rex flasks will facilitate the production of TIL at the numbers required for patient treatment at most cell processing laboratories.

KW - adoptive cell therapy

KW - cancer

KW - G-Rex flasks

KW - melanoma

KW - tumor infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=84863338541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863338541&partnerID=8YFLogxK

U2 - 10.1097/CJI.0b013e31824e801f

DO - 10.1097/CJI.0b013e31824e801f

M3 - Article

C2 - 22421946

AN - SCOPUS:84863338541

VL - 35

SP - 283

EP - 292

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 3

ER -